
==== Front
Arch Virol
Arch. Virol
Archives of Virology
0304-8608 1432-8798 Springer-Verlag Vienna 

1689994
BF01310699
10.1007/BF01310699
Brief Review
Mapping of viral epitopes with prokaryotic expression products
Lenstra J. A.  Kusters J. G.  van der Zeijst B. A. M.  grid.5477.10000000120346234Institute of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Rijksuniversiteit te Utrecht, Utrecht, The Netherlands 
1990 
110 1 1 24
10 10 1989 © Springer-Verlag 1990This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.Summary
Several systems are available for the expression of foreign gene sequences inEscherichia coli. We describe the use of prokaryotic expression products of viral gene fragments in order to identify the regions that specify the binding sites of antibodies. This approach is particulary successful if the antigenicity does not depend on the native protein, but only on the amino acid sequence, i.e., if the epitope is sequential. Combining prokaryotic expression with the use of synthetic peptides often permits a fast and accurate mapping of an epitope. The occurrence of immunodominant sequential epitopes on the surface of viruses seems to be a widespread phenomenon.

Keywords
PeptideInfectious DiseaseAmino Acid SequenceGene SequenceViral Geneissue-copyright-statement© Springer-Verlag 1990
==== Refs
References
1. Abrahmsen L  Moks T  Nilsson B  Uhlen M   Secretion of heterologous gene products to the culture medium ofEscherichia coli  Nucleic Acids Res 1985 14 7487 7501 
2. Acharya R  Fry E  Stuart D  Fox G  Rowlands D  Brown F   The three-dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution Nature 1989 337 709 716 2537470 
3. Aldovini A  Debouck C  Feinberg MB  Rosenberg M  Arya SK  Wong-Staal F   Synthesis of the completetrans -activation gene product of human T-lymphotropic virus type III inEscherichia coli : demonstration of immunogenicity in vivo and expression in vitro Proc Natl Acad Sci USA 1986 83 6672 6676 3018743 
4. Amann E  Brosius J  Ptashne M   Vectors bearing a hybrid trp-lac promoter useful for regulated expression of cloned genes inEscherichia coli  Gene 1983 25 167 178 6363212 
5. Amann E  Brosius J   ‘Atg vectors’ for regulated high-level expression of clones genes inEscherichia coli  Gene 1985 40 183 190 3007288 
6. Arias CF  Ballado T  Plebanski M   Synthesis of the outer-capsid glycoprotein of the simian rotavirus SA11 inEscherichia coli  Gene 1986 47 211 219 3030891 
7. Atassi MZ   Antigenic structures of proteins Eur J Biochem 1984 145 1 20 6208027 
8. Azad AA  Fahey KJ  Barrett SA  Erny KM  Hudson PJ   Expression inEscherichia coli  of cDNA fragments encoding the gene for the host-protective antigen of infectious bursal disease virus Virology 1986 149 190 198 3004025 
9. Banapour B  Rosenthal K  Rabin L  Sharma V  Young L  Fernandez J  Engleman E  McGrath M  Reyes G  Lifson J   Characterization and epitope mapping of a human monoclonal antibody reactive with the envelope glycoprotein of human immunodeficiency virus J Immunol 1987 139 4027 4033 2447158 
10. Benjamin DC  Berzofsky JA  East IJ  Gurd FRN  Hannum C  Leach SJ  Margoliash E  Michael JG  Miller A  Prager EM  Reichlin M  Sercarz EE  Smith-Gill SJ  Todd PE  Wilson AC   The antigenic structure of proteins: a reappraisal Ann Rev Immunol 1984 2 67 101 6085753 
11. Berzofsky JA   Intrinsic and extrinsic factors in protein antigenic structure Science 1985 229 932 940 2410982 
12. Bialy H   Recombinant proteins: virtual authenticity Biotechnology 1987 5 883 891 
13. Bressan GM  Stanley KK   pUEX, a bacterial expression vector related to pEX with universal host specificity Nucleic Acids Res 1987 15 10056 3320953 
14. Broekhuijsen MP  Blom T  Kottenhagen M  Pouwels PH  Meloen RH  Barteling SJ  Enger Valk RE   Synthesis of fusion proteins containing antigenic determinants of foot-and-mouth disease virus Vaccine 1986 4 119 124 2425505 
15. Broekhuijsen MP  Blom T  van Rijn J  Pouwels PH  Klasen EA  Fasbender MJ  Enger-Valk BE   Synthesis of fusion proteins with multiple copies of an antigenic determinant of foot-and-mouth disease virus Gene 1986 49 189 197 2436976 
16. Brown TA   Gene cloning, an introduction 1986 Wokingham, UK Van Nostrand Reinold 
17. Buckland R  Giraudon P  Wild F   Expression of measles virus nucleoprotein inEscherichia coli : use of deletion mutants to locate the antigenic sites J Gen Virol 1989 70 435 441 2471789 
18. Cabrdilla CD  Groopman JE  Lanigan J  Renz M  Lasky LA  Capon DJ   Serodiagnosis of antibodies to the human AIDS retrovirus with a bacterially synthesizedenv  polypeptide Biotechnology 1986 4 128 133 
19. Certa U  Bannwarth W  Stueber D  Gentz R  Lanzer M  le Grice S  Guillot F  Wendler I  Hunsmann G  Bujard H  Mous J   Subregions of a conserved part of the HIV gp41 transmembrane protein are differentially recognized by antibodies of infected individuals EMBO J 1986 5 3051 3056 3491755 
20. Chambers P  Nesbit M  Yusoff K  Millar NS  Samson ACR  Emmerson PT   Location of a neutralizing epitope for the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus J Gen Virol 1988 69 2115 2122 2457068 
21. Cohen GH  Isola VJ  Kuhns J  Berman PW  Eisenberg RJ   Localization of discontinuous epitopes of herpes simplex virus glycoproteins D: use of a nondenaturing (“native” gel) system of polyacrylamide gel electrophoresis coupled with Western blotting J Virol 1986 60 157 166 2427745 
22. Crowl R  Ganguly K  Gordon M  Conroy R  Schaber M  Kramer R  Shaw G  Wong-Staal F  Reddy EP   HLTV-IIIenv  gene products synthesized inE. coli  are recognized by antibodies present in the sera of AIDS patients Cell 1985 41 979 986 2988795 
23. Crowl R  Seamans C  Lomedica P  McAndrew S   Versatile expression vectors for high-level synthesis of cloned gene products inEscherichia coli  Gene 1985 38 31 38 2998948 
24. Davis M  Bjorkman PJ   T-cell antigen receptor genes and T-cell recognition Nature 1988 334 395 401 3043226 
25. Denhardt DT  Colasanti J   Rodriguez RL  Denhardt DT   A survey of vectors for regulating expression of cloned DNA inE. coli  Vectors 1987 Stoneham, MA Butterworths 179 204 
26. Devare SG  Shatzman A  Robbins KC  Rosenberg M  Aaronson SA   Expression of the PDGF-related transforming protein of simian sarcoma virus inE. coli  Cell 1984 36 43 49 6319011 
27. De Vries P  Versteeg-van Oosten JPM  Visser IKG  van Binnendijk RS  Langeveld SA  Osterhaus ADME  Uytdehaag FGCM   Measles virus-specific murine T cell clones: characterization of fine specificity and function J Virol 1989 142 2841 2846 
28. Dietzschold B  Eisenberg RJ  Ponce de Leon M  Golub E  Hudecz F  Varrichio A  Cohen GH   Fine structure analysis of type-specific and type-common antigenic sites of herpes simplex virus glycoprotein D J Virol 1984 52 431 435 6208376 
29. Di Guan G  Li P  Riggs PD  Inouye H   Vectors that facilitate the expression and purification of foreign peptides inEscherichia coli  by fusion to maltose-binding protein Gene 1988 67 21 30 2843437 
30. Doorbar J  Evans HS  Coneron I  Crawford LV  Gallimore PH   Analysis of HPV-1 E4 expression using epitope-defined antibodies EMBO J 1988 7 825 833 2456213 
31. Dowbenko D  Nakamura G  Fennie C  Shimasaki C  Riddle T  Harris R  Gregory T  Lasky L   Epitope mapping of the human immunodeficiency virus type 1 gp 120 with monoclonal antibodies J Virol 1988 62 4703 4711 2460639 
32. Duffaud GD  March PE  Inouye M   Expression and secretion of foreign proteins inEscherichia coli  Methods Enzymol 1987 153 492 507 3323807 
33. Duvoisin RM  Belin D  Krisch HM   A plasmid expression vector that permits stabilization of both mRNAs and proteins encoded by the cloned genes Gene 1986 45 193 201 3026907 
34. Eisenberg RJ  Long D  Ponce de Leon M  Matthews JT  Spear PG  Gibson MG  Lasky LA  Berman P  Golub E  Cohen GH   Localization of epitopes of herpes simplex virus type 1 glycoprotein D J Virol 1985 53 634 644 2578577 
35. Ellis RW  Malcolm Keller P  Lowe RS  Zivin RA   Use of a bacterial expression vector to map the Varicella-Zoster virus major glycoprotein gene, gC J Virol 1985 53 81 88 2981365 
36. Enjuanes L  Gebauer F  Correa I  Bullido MJ  Suñé C  Smerdou C  Sánchez C  Lenstra JA  Posthumus WPA  Meloen RH   Cavanagh D  Brown TDK   Location of antigenic sites of the S-glycoprotein of transmissible gastroenteritis virus and their conservation in coronaviruses Coronaviruses 1989 New York Plenum Press 
37. Francavilla M  Miranda P  di Matteo A  Sarasani A  Gerna G  Milanesi G   Expression of bovine rotavirus neutralization antigen inEscherichia coli  J Gen Virol 1987 68 2975 2980 2824674 
38. Gan Z-R  Condra JH  Gould RJ  Zivin RA  Bennet CD  Jacobs JW  Friedman PA  Polokoff MA   High-level expression inEscherichia coli  of a chemically synthesized gene for [Leu-28]echistatin Gene 1989 79 159 166 2673933 
39. Germino J  Bastia D   Rapid purification of a cloned gene product by genetic fusion and site-specific proteolysis Proc Natl Acad Sci USA 1984 81 4692 4696 6087342 
40. Geysen HM  Rodda SJ  Mason TJ  Tribbick G  Schoofs PG   Strategies for epitope mapping using peptide synthesis J Immunol Methods 1987 102 259 274 2443575 
41. Gill DS  Takai S  Portner A  Kingsbury DW   Mapping of antigenic domains of Sendai virus nucleocapsid protein expressed inEscherichia coli  J Virol 1988 62 4805 4808 2460644 
42. Gilmore RD Jr  Engelking HM  Manning DS  Leong JC   Expression inEscherichia coli  of an epitope of the glycoprotein of infectious hematopoietic necrosis virus protects against virual challenge Biotechnology 1988 6 295 300 
43. Gnann JW Jr  Nelson JA  Oldstone MBA   Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus J Virol 1987 61 2639 2641 2439707 
44. Goudsmit J  Debouck C  Meloen RH  Smit L  Bakker M  Asher DM  Wolff AV  Gibbs CJ Jr  Gajdusek DC   Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees Proc Natl Acad Sci USA 1988 85 4478 4482 2454471 
45. Gray NR  Mazzara GP  Reddy P  Rosbash M   Searching for clones with open reading frames Methods Enzymol 1987 154 129 156 3431458 
46. Grosfeld H  Velan B  Leitner M  Cohen S  Lustig S  Lachmi B-E  Shafferman A   Semliki Forest virus E2 envelope epitopes induce a nonneutralizing humoral response which protects mice against lethal challenge J Virol 1989 63 3416 3422 2473217 
47. Han JH  Rutter WJ   Lambda gt22, an improved lambda vector for the directional cloning of full-length cDNA Nucleic Acids Res 1987 15 6304 2957645 
48. Hasnain SE  Manavathu EK  Leung WC   pXmnATG: anE. coli  vector for expression of unfused proteins Nucleic Acids Res 1987 15 3925 3295785 
49. Hoatlin ME  Kew OM  Renz ME   Regions of poliovirus protein VP 1 produced inEscherichia coli  induce neutralizing antibodies J Virol 1987 61 1442 1447 3033273 
50. Hofbauer JM  Schulz TF  Hengster P  Larcher C  Zangerle R  Kofler H  Fritsch P  Wachter H  Dierich MP   Comparison of Western blot (immunoblot) based on recombinant-derived p41 with conventional tests for serodiagnosis of human immunodeficiency virus infections J Clin Microbiol 1988 26 116 120 3277988 
51. Hubenthal-Voss J  Houghten RA  Pereira L  Roizman B   Mapping of functional and antigenic domains of the α4 protein of herpes simplex virus 1 J Virol 1988 62 454 462 2447289 
52. Jenison SA  Yu X-P  Valentine JM  Galloway DA   Human antibodies react with an epitope of the human papillomavirus type 6 b L 1 open reading frame which is distinct from the type-common epitope J Virol 1989 63 809 818 2463384 
53. Kanner SB  Cheng-Mayer C  Geffin RB  Parks WP  Beltz GA  Arthur LO  Samuel KP  Papas TS   Human retroviralenv  andgag  polypeptides: serologic assays to measure infection J Immunol 1986 137 674 678 3014000 
54. Kato C  Kobayashi T  Kudo T  Furusato T  Murakami Y  Tanaka T  Baba H  Oishi T  Ohtsuka E  Ikehara M  Yanagida T  Kato H  Moriyama S  Horikoshi K   Construction of an excretion vector and extracellular production of human growth hormone fromEscherichia coli  Gene 1987 54 197 202 2820841 
55. Keegan K  Collett MS   Use of bacterial expression cloning to define the amino acid sequences of antigenic determinants on the G2 glycoprotein of Rift Valley fever virus J Virol 1986 58 263 270 2422392 
56. Kocken CHM  Geerligs HJ  Bos CA  AB G  Weijer WJ  Drijfhout J-W  Welling GW  Welling-Wester S   Immunological properties of an N-terminal fragment of herpes simplex virus type 1 glycoprotein D expressed inEscherichia coli  Arch Virol 1988 103 267 274 2850785 
57. Kocken CHM  Scheer JMJ  Welling GW  Welling-Wester S   Purification of fusion proteins expressed by pEX 3 and a truncated pEX 3 derivative FEBS Lett 1988 236 132 134 3136038 
58. Kocken CHM   Recombinant fusion proteins of herpes simplex virus type 1 glycoprotein D 1989 The Netherlands State University of Groningen 
59. Koenen M  Ruether U  Mueller-Hill B   Immunoenzymatic detection of expressed gene fragments cloned in the lac Z gene ofE. coli  EMBO J 1982 4 509 512 
60. Koito A  Hattori T  Matsushita S  Maeda Y  Nozaki C  Sagawa K  Takatsuki K   Conserved immunogenic region of a major core protein (p24) of human and simian immunodeficiency viruses AIDS Res Hum Retroviruses 1988 4 409 417 2464360 
61. Kusters JG  Jager EJ  Lenstra JA  Koch G  Posthumus WPA  Meloen RH  van der Zeijst BAM   Analysis of an immunodominant region of infectious bronchitits virus J Immunol 1989 143 2692 2698 2477454 
61a. Kusters JG  Jager EJ  van der Zeijst BAM   Improvement of the cloning linker of the bacterial expression vector pEX Nucleic Acids Res 1989 17 8007 2678010 
62. Lamb JR  Ivanyi J  Rees ADM  Rothbard JB  Howland K  Young RA  Young DB   Mapping of T cell epitopes using recombinant antigens and synthetic peptides EMBO J 1987 6 1245 1249 2440673 
63. Lautenberger JA  Court D  Papas TS   High-level expression inEscherichia coli  of the carboxy-terminal sequences of the avian myelocytomatosis virus (MC29) v-myc protein Gene 1983 23 75 84 6311677 
64. Lawrence WR  Nagy E  Duncan R  Krell P  Dobos P   Expression inEscherichia coli  of the major outer capsid protein of infectious pancreatic necrosis virus Gene 1989 79 369 374 2507397 
65. Lecocq JP  Zukowski M  Lathe R   Cloning and expression of viral antigens inEscherichia coli  and other microorganisms Methods Virol 1984 7 121 172 
66. Lenstra JA  Kusters JG  Koch G  van der Zeijst BAM   Antigenicity of the peplomer protein of infectious bronchitis virus Mol Immunol 1989 26 7 15 2467199 
67. Luytjes WL  Geerts D  Posthumus W  Meloen R  Spaan W   Amino acid sequence of a conserved neutralizing epitope of murine coronaviruses J Virol 1989 63 1408 1412 2464703 
68. Maina CV  Riggs PS  Grandea AG III  Slatko BE  Moran LS  Tagliamonte JA  McReynolds LA  di Guan C   AnEscherichia coli  vector to express and purify foreign proteins by fusion to and separation from maltose-binding protein Gene 1988 74 365 373 3073105 
69. Marston FAO   Purification of eukaryotic polypeptides synthesized inEscherichia coli  Biochem J 1986 240 1 12 3548705 
70. Matsushita S  Robert-Guroff M  Rusche J  Koito A  Hattori T  Hoshino H  Javaherian K  Takatsuki K  Putney S   Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope J Virol 1988 62 2107 2114 2452899 
71. McCrae MA  McCorquodale JG   Expression of a major bovine rotavirus neutralization antigen (VP 7c) inEscherichia coli  Gene 1987 55 9 18 3040532 
72. Mehra V  Sweetser D  Young RA   Efficient mapping of protein antigenic determinants Proc Natl Acad Sci USA 1986 83 7013 7017 2428046 
73. Meloen RH  Puyk WC  Meijer DJA  Lankhof H  Posthumus WPA  Schaper WMM   Antigenicity and immunogenicity of synthetic peptides of foot-and-mouth disease virus J Gen Virol 1987 68 305 314 2434606 
74. Meloen RH  Liskamp RM  Goudsmit J   Specificity and function of the individual amino acids of an important determinant of human immunodeficiency virus type I that induces neutralizing activity J Gen Virol 1989 70 1505 1512 2471813 
75. Milman G   Expression plasmid containing the λP L  promotor and cI857 repressor Methods Enzymol 1987 153 482 491 2828847 
76. Mitraki A  King J   Protein folding intermediates and inclusion body formation Biotechnology 1989 7 690 697 
77. Mole SE  Lane DP   Use of simian virus 40 large T-β-galactosidase fusion proteins in an immunochemical analysis of simian virus 40 large T antigen J Virol 1985 54 703 710 2987525 
78. Murray K  Bruce SA  Wingfield P  van Eerd P  de Reus A  Schellekens H   Protective immunization against hepatitis B with an internal antigen of the virus J Med Virol 1987 23 101 107 2445909 
79. Nagai K  Thøgersen HC   Synthesis and sequence-specific proteolysis of hybrid proteins produced inEscherichia coli  Methods Enzymol 1987 153 461 481 3323806 
80. Nagata L  Masri SA  Pon RT  Lee PWK   Analysis of functional domains on reovirus cell attachment protein sigma 1 using cloned S 1 gene deletion mutants Virology 1987 160 162 168 3629973 
81. Nilsson B  Abrahmsen L  Uhlen M   Immobilization and purification of enzymes with staphylococcal protein A gene fusion vectors EMBO J 1984 4 1075 1080 
82. Nunberg JH  Rodgers G  Gilbert JH  Snead RM   Method to map antigenic determinants recognized by monoclonal antibodies: localization of a determinant of virus neutralization on the feline leukemia envelope protein gp 70 Proc Natl Acad Sci USA 1984 81 3675 3679 6203125 
83. Padberg C  Nowlan S  Mermer B   Recombinant polypeptides from the human immunodeficiency virus reverse transcriptase define three epitopes recognized by antibodies in sera from patients with acquired immunodeficiency syndrome AIDS Res Hum Retroviruses 1989 5 61 71 2470400 
84. Page GS  Mosser AG  Hogle JM  Filman DJ  Rueckert RR  Chow M   Three-dimensional structure of poliovirus serotype 1 neutralizing determinants J Virol 1988 62 1781 1794 2451757 
85. Palker TJ  Matthews TJ  Clark ME  Cianciolo GJ  Randall RR  Langlois AJ  White GC  Safai B  Snyderman R  Bolognesi DP  Haynes BF   A conserved region at the COOH terminus of human immunodeficiency virus gp 120 envelope protein contains an immunodominant epitope Proc Natl Acad Sci USA 1987 84 2479 2483 2436231 
86. Papas TS  Samuel KP  Kan NC  Ascione R  Wong-Staal F  Lautenberger   Production of oncogene-specific proteins and human T-cell leukemia (lymphotropic) retrovirus (HLTV-I) envelope protein in bacteria and its potential for use in human cancers and seroepidemiological surveys Cancer Res 1985 45 4568s 4573s 2861893 
87. Parry NR  Barnett PV  Ouldridge EJ  Rowlands DJ  Brown F   Neutralizing epitopes of type 0 foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents J Gen Virol 1989 70 1493 1503 2471812 
88. Posthumus WPA  Meloen RH  Enjuanes L  Correa I  van Nieuwstadt AP  Koch G  de Groot RJ  Kusters JG  Luytjes W  Spaan WJ  van der Zeijst BAM  Lenstra JA   Cavanagh D  Brown TDK   Linear neutralizing epitopes on the peplomer protein of coronaviruses Coronaviruses 1989 New York Plenum Press 
89. Pouwels PH  Enger-Valk BE  Brammar WJ   Cloning vectors. A laboratory manual 1987 Amsterdam Elsevier 
90. Putney SD  Matthews TJ  Robey WG  Lynn DL  Robert-Goroff M  Mueller WT  Langlois AJ  Ghrayeb J  Petteway SR Jr  Weinhold KJ  Fischinger PJ  Wong-Staal F  Gallo RC  Bolognesi DP   HTLV-III/LAV-neutralizing antibodies to anE. coli -produced fragment of the virus envelope Science 1986 234 1393 1395 
91. Rimm DL  Pollard TD   New plasmid vectors for high level expression of eukaryotic fusion proteins inEscherichia coli  Gene 1989 75 323 327 2653968 
92. Roeckel D  Boos H  Mueller-Lantzsch N   Expression of an early Epstein-Barr virus antigen (EA-D) inE. coli  Arch Virol 1987 97 365 372 2827613 
93. Rosenberg M  Rosenberg H Y  Shatzman A   The use of pKC 30 and its derivatives for controlled expression of genes Methods Enzymol 1983 101 123 138 6310317 
94. Rossmann MG  Arnold E  Erickson JW  Frankenberger EA  Griffith JP  Hecht HJ  Johnson JE  Kamer G  Luo M  Mosser AG  Rueckert RR  Sherry B  Vriend G   Structure of a human common cold virus and functional relationship to other picornaviruses Nature 1985 317 145 153 2993920 
95. Rowe DT  Clarke JR   The type-specific epitopes of the Epstein-Barr virus nuclear antigen 2 are near the carboxy terminus of the protein J Gen Virol 1989 70 1217 1229 2471806 
96. Rothbard JB   Peptides and the cellular immune response Ann Inst Pasteur/Virol 1986 137E 518 528 
97. Rothbard JB  Taylor WR   A sequence pattern common to T cell epitopes EMBO J 1988 7 93 100 2452085 
98. Rüther U  Koenen M  Sippel AE  Müller-Hill B   Exon cloning: immunoenzymatic identification of exons of the chicken lysozyme gene Proc Natl Acad Sci USA 1982 79 6852 6855 6184717 
99. Rüther U  Müller-Hill B   Easy identification of cDNA clones EMBO J 1983 2 1791 1794 6315402 
100. Salfeld J  Pfaff E  Noah M  Schaller H   Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus J Virol 1989 63 798 808 2463383 
101. Sambrook J  Fritsch EF  Maniatis T   Molecular cloning. A laboratory manual 1989 2nd edn. Cold Spring Harbor, NY Cold Spring Harbor Laboratory 
102. Samuel KP  Flordellis CS  DuBois GC  Papas TS   High-level bacterial expression and purification of human T-lymphotropic virus type I (HTLV-1) transmembrane env protein Gene Anal Techn 1985 2 60 66 
103. Schödel F  Will H   Construction of a plasmid for expression or foreign epitopes as fusion with subunit B ofEscherichia coli  heat-labile enterotoxin Infect Immun 1989 57 1347 1350 2647637 
104. Schoner BE  Belagaje RM  Schoner RG   Expression of eukaryotic genes inEscherichia coli  with a synthetic two-cistron system Methods Enzymol 1987 153 401 416 2828844 
105. Schrier RD  Gnann JW Jr  Langlois AJ  Shriver K  Nelson JA  Oldstone MBA   B- and T-lymphocyte responses to an immunodominant epitope of human immunodeficiency virus J Virol 1988 62 2531 2536 3260630 
106. Sela M   Antigenicity: some molecular aspects Science 1969 166 1365 1374 4900368 
107. Seth A  Lapis P  vande Woude GF  Papas T   High-level expression vectors to synthesize unfused proteins inEscherichia coli  Gene 1986 42 49 57 3522356 
108. Shatzman AR  Rosenberg M   Expression, identification, and characterization of recombinant gene products inEscherichia coli  Methods Enzymol 1987 152 661 673 2821359 
109. Sieg K  Kun J  Pohl I  Scherf A  Müller-Hill   A versatile phage lambda expression vector system for cloning inEscherichia coli  Gene 1989 75 261 270 2469628 
110. Sisk WP  Chirikjian JG  Lautenberger J  Jorcyk C  Papas TS  Berman ML  Zagursky R  Court DL   A plasmid vector for cloning and expression of gene segments: expression of an HTLV-I envelope gene segment Gene 1986 48 183 193 2881844 
111. Skern T  Neubauer C  Frasel L  Gruendler P  Sommergruber W  Zorn M  Kuechler E  Blaas D   A neutralizing epitope on human rhinovirus type 2 includes amino acid residues between 153 and 164 of virus capsid protein VP2 J Gen Virol 1987 68 315 323 2434607 
112. Smith S  Halling SM   Expression of canine parvovirus-β-galactosidase fusion proteins inEscherichia coli  Gene 1984 29 263 269 6208084 
113. Smith DB  Johnson KS   Single-step purification of polypeptides expressed inEscherichia coli  as fusions with glutathione S-transferase Gene 1988 67 31 40 3047011 
114. Snijders A  Benaissa-Trouw BJ  Oosting JD  Snippe H  Kraaijeveld CA   Identification of a DTH inducing T-cell epitope on the E2 membrane protein of Semliki Forest virus Cell Immunol 1989 123 25 35 
115. Stanley KK   Solubilization and immune-detection of β-galactosidase hybrid proteins carrying foreign antigenic determinants Nucleic Acids Res 1983 11 4077 4092 6191278 
116. Stanley KK  Luzio JP   Construction of a new family of high efficiency bacterial expression vectors: identification of cDNA clones coding for human liver proteins EMBO J 1984 3 1429 1434 6086324 
117. Stanley KK  Herz J  Dickson J   Topological mapping of complement C9 by recombinant DNA techniques suggests a novel mechanism for its insertion into target membranes EMBO J 1987 6 1951 1957 2443347 
118. Stoker NG  Grant KA  Dockrell HM  Howard CR  Jouy NF  McAdam KPWJ   High level expression of genes clones in λgt11 Gene 1989 78 93 99 2527780 
119. Strebel K  Beck E  Strohmaier K  Schaller H   Characterization of foot-and-mouth disease virus gene products with antisera against bacterially synthesized fusion proteins J Virol 1986 57 983 991 3005640 
120. Tai T-N  Havelka WA  Kaplan S   A broad-host-range vector system for cloning and translational lacZ fusion analysis Plasmid 1988 19 175 188 2852814 
121. Tainer JA  Getzoff ED  Paterson Y  Olson AJ  Lerner RA   The atomic mobility component of protein antigenicity Annu Rev Immunol 1985 3 501 535 2415142 
122. Tooze SA  Stanley KK   Identification of two epitopes in the carboxyterminal 15 amino acids of the E 1 glycoprotein of mouse hepatitis virus A 59 by using hybrid proteins J Virol 1986 60 928 934 2431163 
123. Tsukamoto AS  Ferguson BV  Rosenberg M  Weissman IL  Berk AJ   An immunodominant domain in adenovirus type 2 early region 1 A proteins J Virol 1986 60 312 316 2427749 
124. Utz U  Britt W  Vugler L  Mach M   Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus J Virol 1989 63 1995 2001 2467992 
125. Van der Werf S  Wychowski C  Bruneau P  Blondel B  Crainic R  Horodniceanu F  Girard M   Localization of a poliovirus type 1 neutralization epitope in viral capsid polypeptide VP1 Proc Natl Acad Sci USA 1983 80 5080 5084 6308670 
126. Van der Zee R  van Eden W  Meloen RH  Noordzij A  van Embden JDA   Efficient mapping and characterization of a T cell epitope by the simultaneous synthesis of multiple peptides Eur J Immunol 1989 19 43 47 2465904 
127. Van Eden W  Thole JER  van der Zee R  Noordzij A  van Embden JDA  Hensen EJ  Cohen IR   Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis Nature 1988 331 171 173 2448638 
128. Van Regenmortel MHV  Neurath AR   van Regenmortel MHV  Neurath AR   Structure of viral antigens Immunochemistry of viruses. The basis for serodiagnosis and vaccines 1985 Amsterdam Elsevier 1 11 
129. Van Regenmortel MHV   Antigenic cross-reactivity between proteins and peptides: new insights and applications Trends Biochem Sci 1987 12 237 240 
130. Van Regenmortel MHV  Muller S  Quesniaux VF  Altschuh D  Briand JP   Kohler H  LoVerde PT   Operational aspects of epitope identification: structural features of proteins recognized by antibodies Vaccines: new concepts and developments 1988 London Longman 113 122 
131. Van Regenmortel MHV   Structural and functional approaches to the study of protein antigenicity Immunol Today 1989 10 266 271 2478146 
132. Versteeg-van Oosten J  Langeveld S  Voorma HO  Weisbeek P  de Vries P  Osterhaus A  Uytdehaag F  Meloen R   Lerner R A  Ginsberg H  Chanock RM  Brown F   Epitope mapping of the fusion protein of measles virus Vaccines 89 1989 Cold Spring Harbor, NY Cold Spring Harbor Laboratory 521 527 
133. Watson G  Burdon MG  Russell WC   An antigenic analysis of the adenovirus type 2 fibre polypeptide J Gen Virol 1988 69 525 535 2450964 
134. Weinstock GM  Ap Rhys C  Berman ML  Hampar B  Jackson D  Silhavy TJ  Weisemann J  Zweig M   Open reading frame expression vectors: a general method for antigen production inEscherichia coli  using protein fusions to β-galactosidase Proc Natl Acad Sci USA 1983 80 4432 4436 6308625 
135. Weinstock GM   Use of open reading frame expression vectors Methods Enzymol 1987 154 156 163 3323809 
136. Westhof E  Altschuh D  Moras D  Bloomer AC  Mondragon A  Klug A  van Regenmortel MHV   Correlation between segmental mobility and the location of antigenic determinants in proteins Nature 1984 311 123 126 6206398 
137. Wiley DC  Wilson IA  Skehel JJ   Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation Nature 1981 289 373 378 6162101 
138. Winther MD  Allen G  Bomford RH  Brown F   Bacterially expressed antigenic peptide from foot-and-mouth disease virus capsid elicits variable immunologic responses in animals J Immunol 1986 136 1835 1840 3005401 
139. Windheuser MG  Wood C   Characterization of immunoreactive epitopes of the HIV-1 p41 envelope protein using fusion proteins synthesized inEscherichia coli  Gene 1988 64 107 119 2456255 
140. Windheuser MG  Tegtmeier GE  Wood C   Use of trpE/gag fusion proteins to characterize immunoreactive domains on the human immunodeficiency virus type 1 core protein J Immunol 1989 63 4064 4068 
141. Wychowski C  van der Werf S  Siffer O  Crainic R  Bruneau P  Girard M   A poliovirus type 1 neutralization epitope is located within amino acid residues 93–104 of viral capsid polypeptide VP1 EMBO J 1983 2 2019 2024 6196195 
142. Young RA  Davis RW   Efficient isolation of genes by using antibody probes Proc Natl Acad Sci USA 1983 80 1194 1198 6219389

